Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALB Albemarle	$64.94 +1.9%	$59.08	$49.43 ▼ $113.91	$7.64B	1.61	2.85 million shs	4.14 million shs
MRNA Moderna	$27.16 -1.4%	$26.41	$23.15 ▼ $129.39	$10.50B	1.86	8.58 million shs	11.54 million shs
NOW ServiceNow	$1,023.56 +1.2%	$985.61	$678.66 ▼ $1,198.09	$211.62B	0.95	1.49 million shs	1.51 million shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALB Albemarle	0.00%	+14.50%	+12.88%	-10.07%	-35.24%
MRNA Moderna	0.00%	+4.86%	+0.85%	-12.72%	-77.82%
NOW ServiceNow	0.00%	+5.55%	+0.82%	+28.49%	+35.70%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALB Albemarle	4.3763 of 5 stars	4.1	1.0	2.5	0.6	3.5	1.7	1.3
MRNA Moderna	4.5163 of 5 stars	4.0	2.0	0.0	4.6	1.2	2.5	1.3
NOW ServiceNow	4.4118 of 5 stars	2.5	5.0	0.0	2.5	2.9	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALB Albemarle	2.14	Hold	$91.62	41.08% Upside
MRNA Moderna	2.04	Hold	$46.61	71.62% Upside
NOW ServiceNow	2.94	Moderate Buy	$1,065.32	4.08% Upside

Current Analyst Ratings Breakdown

Latest NOW, ALB, and MRNA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/25/2025	NOW ServiceNow	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$1,150.00
6/12/2025	NOW ServiceNow	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$1,050.00 ➝ $1,100.00
6/11/2025	NOW ServiceNow	FBN Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/2/2025	MRNA Moderna	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
5/22/2025	MRNA Moderna	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Underweight ➝ Underweight	$33.00 ➝ $26.00
5/14/2025	ALB Albemarle	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Underweight ➝ Underweight	$68.00
5/14/2025	NOW ServiceNow	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$1,025.00 ➝ $1,150.00
5/7/2025	NOW ServiceNow	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Outperform ➝ Outperform	$1,100.00
5/7/2025	NOW ServiceNow	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$1,085.00
5/7/2025	NOW ServiceNow	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$1,128.00 ➝ $1,160.00
5/6/2025	NOW ServiceNow	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$970.00 ➝ $1,100.00

(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALB Albemarle	$5.38B	1.42	$3.83 per share	16.97	$67.76 per share	0.96
MRNA Moderna	$3.24B	3.25	N/A	N/A	$28.33 per share	0.96
NOW ServiceNow	$10.98B	19.29	$12.73 per share	80.41	$46.65 per share	21.94

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALB Albemarle	-$1.18B	-$11.12	N/A	34.00	N/A	-22.39%	-1.92%	-0.92%	7/30/2025 (Estimated)
MRNA Moderna	-$3.56B	-$8.73	N/A	N/A	N/A	-105.67%	-28.69%	-21.94%	7/30/2025 (Estimated)
NOW ServiceNow	$1.43B	$7.36	139.07	89.08	4.70	13.41%	17.34%	8.38%	7/23/2025 (Estimated)

Latest NOW, ALB, and MRNA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/23/2025	Q2 2025	NOW ServiceNow	$3.53	N/A	N/A	N/A	$3.12 billion	N/A
5/1/2025	Q1 2025	MRNA Moderna	-$2.92	-$2.52	+$0.40	-$2.52	$130.35 million	$108.00 million
4/30/2025	Q1 2025	ALB Albemarle	-$0.62	-$0.18	+$0.44	N/A	$1.18 billion	$1.08 billion
4/23/2025	Q1 2025	NOW ServiceNow	$3.78	$4.04	+$0.26	$2.20	$3.09 billion	$3.09 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALB Albemarle	$1.62	2.49%	N/A	N/A	30 Years
MRNA Moderna	N/A	N/A	N/A	N/A	N/A
NOW ServiceNow	N/A	N/A	N/A	N/A	N/A

Latest NOW, ALB, and MRNA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/6/2025	ALB Albemarle	quarterly	$0.4050	2.82%	6/13/2025	6/13/2025	7/1/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALB Albemarle	0.39	2.11	1.26
MRNA Moderna	N/A	4.22	4.14
NOW ServiceNow	0.15	1.12	1.12

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALB Albemarle	92.87%
MRNA Moderna	75.33%
NOW ServiceNow	87.18%

Insider Ownership

Company	Insider Ownership
ALB Albemarle	0.33%
MRNA Moderna	11.00%
NOW ServiceNow	0.38%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALB Albemarle	8,300	117.66 million	117.27 million	Optionable
MRNA Moderna	5,800	386.74 million	344.20 million	Optionable
NOW ServiceNow	26,293	206.98 million	206.20 million	Optionable

NOW, ALB, and MRNA Headlines

Recent News About These Companies

Mmbg Investment Advisors CO. Acquires New Position in ServiceNow, Inc. (NYSE:NOW)

June 29 at 7:47 AM | marketbeat.com

KBC Group NV Has $147.06 Million Stake in ServiceNow, Inc. (NYSE:NOW)

June 29 at 7:06 AM | marketbeat.com

Goodman Advisory Group LLC Has $2.49 Million Stock Holdings in ServiceNow, Inc. (NYSE:NOW)

June 29 at 6:41 AM | marketbeat.com

Cohen Investment Advisors LLC Buys 349,216 Shares of ServiceNow, Inc. (NYSE:NOW)

June 29 at 6:32 AM | marketbeat.com

CFM Wealth Partners LLC Buys 423 Shares of ServiceNow, Inc. (NYSE:NOW)

June 29 at 5:49 AM | marketbeat.com

Confluence Wealth Services Inc. Buys 412 Shares of ServiceNow, Inc. (NYSE:NOW)

June 29 at 5:41 AM | marketbeat.com

Mirae Asset Global Investments Co. Ltd. Grows Holdings in ServiceNow, Inc. (NYSE:NOW)

June 29 at 5:04 AM | marketbeat.com

ServiceNow (NYSE:NOW) Upgraded to "Buy" at Wall Street Zen

June 29 at 2:47 AM | americanbankingnews.com

ServiceNow, Inc. (NYSE:NOW) Given Average Recommendation of "Moderate Buy" by Analysts

June 29 at 2:25 AM | marketbeat.com

Several Tailwinds Powering ServiceNow India's Growth: Sumeet Mathur

June 28 at 9:41 AM | msn.com

ServiceNow (NOW) Just Got a Price Target Boost—Here’s What’s Behind It

June 28 at 8:59 AM | finance.yahoo.com

Little House Capital LLC Takes Position in ServiceNow, Inc. (NYSE:NOW)

June 28 at 8:18 AM | marketbeat.com

Sumitomo Mitsui Trust Group Inc. Lowers Holdings in ServiceNow, Inc. (NYSE:NOW)

June 28 at 8:16 AM | marketbeat.com

Overbrook Management Corp Reduces Stock Holdings in ServiceNow, Inc. (NYSE:NOW)

June 28 at 8:03 AM | marketbeat.com

Westwind Capital Purchases 827 Shares of ServiceNow, Inc. (NYSE:NOW)

June 28 at 7:54 AM | marketbeat.com

Allspring Global Investments Holdings LLC Purchases 2,015 Shares of ServiceNow, Inc. (NYSE:NOW)

June 28 at 6:47 AM | marketbeat.com

Jag Capital Management LLC Increases Stock Position in ServiceNow, Inc. (NYSE:NOW)

June 28 at 6:12 AM | marketbeat.com

Achmea Investment Management B.V. Boosts Holdings in ServiceNow, Inc. (NYSE:NOW)

June 28 at 5:26 AM | marketbeat.com

DA Davidson Initiates Coverage of ServiceNow (NOW) with a Buy Rating

June 28 at 5:11 AM | insidermonkey.com

ServiceNow, Inc. (NYSE:NOW) Shares Bought by Transcend Capital Advisors LLC

June 28 at 5:07 AM | marketbeat.com

ServiceNow, Inc. (NYSE:NOW) Shares Purchased by Perpetual Ltd

June 28 at 4:46 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Breakout Momentum Plays You May Not Know About
By Nathan Reiff | June 6, 2025
View Breakout Momentum Plays You May Not Know About
Applied Digital: Now the High-Stakes Race to Build Begins
By Jeffrey Neal Johnson | June 17, 2025
View Applied Digital: Now the High-Stakes Race to Build Begins
3 Top Dividend Stocks Analysts Are Bullish on Right Now
By Chris Markoch | June 6, 2025
View 3 Top Dividend Stocks Analysts Are Bullish on Right Now
3 Growth Stocks Too Small for Institutions to Buy
By Gabriel Osorio-Mazilli | June 19, 2025
View 3 Growth Stocks Too Small for Institutions to Buy
Tankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names
By Leo Miller | June 10, 2025
View Tankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names

NOW, ALB, and MRNA Company Descriptions

Albemarle NYSE:ALB

$64.94 +1.19 (+1.87%)

Closing price 06/27/2025 03:59 PM Eastern

Extended Trading

$64.52 -0.42 (-0.65%)

As of 06/27/2025 07:56 PM Eastern

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Specialties segment provides bromine-based specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals; lithium specialties, such as butyllithium and lithium aluminum hydride; develops and manufactures cesium products for the chemical and pharmaceutical industries; and zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators. The Ketjen segment offers clean fuels technologies (CFT), which is composed of hydroprocessing catalysts (HPC) together with isomerization and akylation catalysts; fluidized catalytic cracking (FCC) catalysts and additives; and performance catalyst solutions (PCS), which is composed of organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Moderna NASDAQ:MRNA

$27.16 -0.38 (-1.38%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$27.16 0.00 (-0.02%)

As of 06/27/2025 07:59 PM Eastern

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

ServiceNow NYSE:NOW

$1,023.56 +12.12 (+1.20%)

Closing price 06/27/2025 03:59 PM Eastern

Extended Trading

$1,018.12 -5.44 (-0.53%)

As of 06/27/2025 08:00 PM Eastern

ServiceNow, Inc. provides end to-end intelligent workflow automation platform solutions for digital businesses in the North America, Europe, the Middle East and Africa, Asia Pacific, and internationally. The company operates the Now platform for end-to-end digital transformation, artificial intelligence, machine learning, robotic process automation, process mining, performance analytics, and collaboration and development tools. It also provides asset management, cloud observability, integrated risk management; information technology (IT) service management applications; IT service management product suite for enterprise's employees, customers, and partners; strategic portfolio management product suite; IT operations management product that connects a customer's physical and cloud-based IT infrastructure; IT asset management; and security operations that connects with internal and third party. In addition, the company offers integrated risk management product to manage risk and resilience; environmental, social and governance management product; human resources, legal, and workplace service delivery products; customer service management product; and field service management applications. Further, the company provides app engine product; automation engine; platform privacy and security product; and source-to-pay operations. It serves to government, financial services, healthcare, telecommunications, manufacturing, IT services, technology, oil and gas, education, and consumer products through service providers and resale partners. The company was formerly known as Service-now.com and changed its name to ServiceNow, Inc. in May 2012. ServiceNow, Inc. was founded in 2004 and is headquartered in Santa Clara, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time